Feds crack down on homeopathic weight loss remedy

December 6, 2011 in Medications

(AP) -- Federal regulators are ordering several companies to stop selling an unproven weight loss remedy that uses protein from the human placenta.

The issued warning letters to seven companies that sell the protein as drops, pellets or sprays. Human chorionic gonadotropin is produced by the placenta and found in the urine of pregnant women. While it is approved for certain infertility treatments, the FDA says there is no evidence it helps reduce weight.

Many of the products cited in the warning letters claim to change "abnormal eating patterns," and help people lose 20 to 30 pounds in as little as a month when used with a low-calorie diet, usually around 500 .

Health experts say such restrictive diets can be dangerous.

"These products are marketed with incredible claims and people think that if they're losing weight, HCG must be working," said Elizabeth Miller, of FDA's division for non-prescription drugs and health fraud, in a statement. "But the data simply does not support this - any loss is from severe . Not from the HCG."

The products are advertised as homeopathic remedies, or highly diluted drugs made from natural ingredients and sold with medical claims. Many doctors view homeopathic remedies as ineffective but mostly harmless because the drugs in them are present in such tiny amounts.

But the FDA said the products targeted Tuesday could be dangerous when taken as directed.

Homeopathic treatments are based on principles unverified by mainstream science, and often reference mystical-sounding concepts like "vital force" and "healing energy."

In 1938, Congress passed a law granting homeopathic remedies the same legal status as regular pharmaceuticals. The law's principal author was Sen. Royal Copeland of New York, a trained homeopath.

While regulation of the products is minimal, the FDA maintains a list of approved ingredients that can be used for homeopathic drugs. HCG is not among the approved ingredients.

After decades of declining use, homeopathic remedies have revived in recent decades with the burst of interest in vitamins, herbs and other unconventional treatments.

The companies cited by regulators have 15 days to respond and detail how they intend to remove their products from the market. Failure to do so may result in legal action, including seizure and injunction, or criminal prosecution.

©2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

not rated yet  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Carbon18
Dec 06, 2011

Rank: not rated yet
I often wonder about the apparent harmlessness of these pseudo therapies. They often promote, as demonstrated in this article, potentially dangerous behaviors.
Also in the article the expression " mainstream science " evokes a chuckle.
Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Acne pill benefits outweigh blood clot risk: EU agency

Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.

Medications created 17 hours ago | popularity not rated yet | comments 0

First influenza vaccine brought to clinical testing

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

Medications created 18 hours ago | popularity not rated yet | comments 0

Aspirin not always best treatment for many individuals

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

Medications created May 16, 2013 | popularity 3.5 / 5 (2) | comments 0 | with audio podcast

FDA: lower ambien's dose to prevent drowsy driving

(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...

Medications created May 15, 2013 | popularity not rated yet | comments 0

Simponi approved for ulcerative colitis

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

Medications created May 15, 2013 | popularity not rated yet | comments 0


AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...